Y-mAbs Therapeutics Inc (YMAB)
12.22
-0.18
(-1.45%)
USD |
NASDAQ |
May 24, 16:00
12.22
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Profit Margin (Quarterly): -33.26% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -33.26% |
December 31, 2023 | -4.23% |
September 30, 2023 | -37.88% |
June 30, 2023 | -30.37% |
March 31, 2023 | -31.55% |
December 31, 2022 | 3.68% |
September 30, 2022 | -219.6% |
Date | Value |
---|---|
June 30, 2022 | -380.9% |
March 31, 2022 | -267.7% |
December 31, 2021 | -384.4% |
September 30, 2021 | -321.9% |
June 30, 2021 | -209.5% |
March 31, 2021 | |
December 31, 2020 | -96.06% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-384.4%
Minimum
Dec 2021
3.68%
Maximum
Dec 2022
-154.9%
Average
-96.06%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
The Cooper Companies Inc | 8.72% |
Puma Biotechnology Inc | -11.00% |
Humacyte Inc | -- |
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -21.12% |
Return on Assets | -16.67% |
Return on Invested Capital | -21.12% |
Gross Profit Margin (Quarterly) | 89.23% |
Operating Margin (Quarterly) | -34.66% |
Return on Net Operating Assets | -69.27% |